Skip to main content
SpringerLink
Log in

Assessment of the long-term risks and benefits of combined oral contraceptives

  • Drug Reactions and Interaction
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bagshaw S. The combined oral contraceptive: risks and adverse effects in perspective. Drug Saf 1995; 12(2): 91–6

    Article  PubMed  CAS  Google Scholar 

  2. Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke: evidence from the Royal College of General Practitioners’ oral contraceptive study. Stroke 1994 May; 25(5): 935–42

    Article  PubMed  CAS  Google Scholar 

  3. Lidegaard Ø. Oral contraception and risk of cerebral thromboembolic attack: results of a case-control study. BMJ 1993 Apr 10; 306: 956–63

    Article  PubMed  CAS  Google Scholar 

  4. Lidegaard Ø. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: an incidence study for the period 1980–1993. Contraception 1995 Aug; 52: 85–92

    Article  PubMed  CAS  Google Scholar 

  5. Rimm FB, Manson JE, Stampfer MJ, et al. Oral contraceptives use and the risk of type-2 (non-insulin-dependent) diabetes-mellitus in a large prospective study of women. Diabetologia 1992 Oct; 35: 967–72

    Article  PubMed  CAS  Google Scholar 

  6. Schlesselman JJ. Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet Gynecol 1995 May; 85 (5 part 1): 793–801

    Google Scholar 

  7. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995 Jun 7; 87(11): 827–35

    Article  PubMed  CAS  Google Scholar 

  8. Rookus MA, van Leeuwen FE. Oral contraceptives and risk of breast cancer in women aged 20–54 years. Lancet 1994 Sep 24; 344: 844–51

    Article  PubMed  CAS  Google Scholar 

  9. Mant JWF, Vessey MR Trends in mortality from primary liver cancer in England and Wales 1975–1992; influence of oral contraceptives. Br J Cancer 1995 Sep; 72: 800–3

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assessment of the long-term risks and benefits of combined oral contraceptives. Drugs Ther. Perspect 6, 9–11 (1995). https://doi.org/10.2165/00042310-199506100-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506100-00004

Search

Navigation